The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases

255Citations
Citations of this article
285Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), is a secreted glycoprotein that belongs to a group of transporters of small lipophilic molecules in circulation. LCN2 has been recently characterized as an adipose-derived cytokine. This adipokine is believed to bind small substances, such as steroids and lipopolysaccharides, and has been reported to have roles in the induction of apoptosis in hematopoietic cells, transport of fatty acids and iron, modulation of inflammation, and metabolic homeostasis. Recently, LCN2 has emerged as a useful biomarker and rheumatic diseases. This review provides an overview of LCN2 in inflammation, immunity, and metabolism.

Cite

CITATION STYLE

APA

Abella, V., Scotece, M., Conde, J., Gómez, R., Lois, A., Pino, J., … Gualillo, O. (2015). The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers, 20(8), 565–571. https://doi.org/10.3109/1354750X.2015.1123354

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free